Atorolimumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | RhD |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number |
202833-08-7 ![]() |
ChemSpider | none |
![]() ![]() |
Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.[1]
References
Intracellular (initiation) |
| ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||||||||||
Extracellular |
|
This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.